These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 699970)

  • 21. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in (3H)-ADTN binding to microsomal and synaptic membrane fractions from rat striata following kainic acid lesions.
    Davis A; Woodruff GN; Poat JA; Freedman SB
    Biochem Pharmacol; 1980 Jun; 29(12):1645-8. PubMed ID: 7406893
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
    Westerink BH; Dijkstra D; Feenstra MG; Horn AS; Rollema H
    Eur J Pharmacol; 1980 Jun; 64(2-3):115-21. PubMed ID: 7398758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of R(+)-ADTN in dopamine receptor binding assays.
    Davis A; Poat JA; Woodruff GN
    Eur J Pharmacol; 1980 May; 63(2-3):237-8. PubMed ID: 6155278
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ; Horowitz SG; Dvorkin B; Makman MH
    Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guanine nucleotides regulate anterior pituitary dopamine receptors.
    Sibley DR; Creese I
    Eur J Pharmacol; 1979 May; 55(3):341-3. PubMed ID: 456433
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.
    Clement-Cormier Y; Smith CE
    Neurochem Res; 1980 Jun; 5(6):641-51. PubMed ID: 7402434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous components of the striatum confer dopamine-sensitivity upon adenylate cyclase activity: the role of endogenous guanyl nucleotides.
    Chen TC; Cote TE; Kebabian JW
    Brain Res; 1980 Jan; 181(1):139-49. PubMed ID: 7350949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA; Finch CE
    Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an exclusive localization of 3H-ADTN binding sites to postsynaptic nerve cells in the striatum of the rat.
    Fuxe K; Hall H; Köhler C
    Eur J Pharmacol; 1979 Oct; 58(4):515-7. PubMed ID: 510387
    [No Abstract]   [Full Text] [Related]  

  • 34. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden CD
    Mol Pharmacol; 1986 Sep; 30(3):226-34. PubMed ID: 2943980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and derivatives.
    Creese I; Manian AA; Prosser TD; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):291-6. PubMed ID: 631182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE; Hamblin MW; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
    Snavely MD; Insel PA
    Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
    J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.